Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Eli Lilly and Company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pfizer
City of Hope Medical Center
RemeGen Co., Ltd.
Regeneron Pharmaceuticals
University of Oklahoma
NRG Oncology
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
AstraZeneca
University Health Network, Toronto
Cullinan Therapeutics Inc.
Enliven Therapeutics
Amgen
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
University of Pennsylvania
University of Southern California
Dana-Farber Cancer Institute
Toray Industries, Inc
Washington University School of Medicine
DEKA Biosciences